Search Results - Abdulrahman, Hadiza Lawal

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Computational pharmacokinetic analysis on some newly designed 2-anilinopyrimidine derivative compounds as anti-triple-negative breast cancer drug compounds

    Computational pharmacokinetic analysis on some newly designed 2-anilinopyrimidine derivative compounds as anti-triple-negative breast cancer drug compounds by Abdulrahman, Hadiza Lawal, Uzairu, Adamu, Uba, Sani

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Computer modeling of some anti-breast cancer compounds

    Computer modeling of some anti-breast cancer compounds by Abdulrahman, Hadiza Lawal, Uzairu, Adamu, Uba, Sani

    Published in Structural chemistry
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line

    In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line by Ikwu, Fabian Adakole, Isyaku, Yusuf, Obadawo, Babatunde Samuel, Lawal, Hadiza Abdulrahman, Ajibowu, Samuel Akolade

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    In silico studies of some 2-anilinopyrimidine derivatives as anti-triple-negative breast cancer agents

    In silico studies of some 2-anilinopyrimidine derivatives as anti-triple-negative breast cancer agents by Abdulrahman, Hadiza Lawal, Uzairu, Adamu, Uba, Sani

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds

    QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative br... by Lawal, Hadiza Abdulrahman, Uzairu, Adamu, Uba, Sani

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    QSAR, Ligand Based Design and Pharmacokinetic Studies of Parviflorons Derivatives as Anti-Breast Cancer Drug Compounds Against MCF-7 Cell Line

    QSAR, Ligand Based Design and Pharmacokinetic Studies of Parviflorons Derivatives as Anti-Breast Cancer Drug Compounds Against MCF-7 Cell Line by Abdulrahman, Hadiza Lawal, Uzairu, Adamu, Uba, Sani

    Published in Chemistry Africa
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line

    QSAR, molecular docking, design, and pharmacokinetic analysis of 2-(4-fluorophenyl) imidazol-5-ones as anti-breast cancer drug compounds against MCF-7 cell line by Lawal, Hadiza Abdulrahman, Uzairu, Adamu, Uba, Sani

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: